187 results on '"Poon, Ronnie T.P."'
Search Results
2. Data from Granulin–Epithelin Precursor Renders Hepatocellular Carcinoma Cells Resistant to Natural Killer Cytotoxicity
3. Supplementary Data from An Akt/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
4. Supplementary Figure 1 from A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
5. Supplementary Data from Brain-Derived Neurotrophic Factor Promotes Tumorigenesis via Induction of Neovascularization: Implication in Hepatocellular Carcinoma
6. Supplementary Table 1-3, Supplementary Figure Legend from A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
7. Supplementary Figure Legends 1-3 from Lupeol Suppresses Cisplatin-Induced Nuclear Factor-κB Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model
8. Supplementary Figures 1-6 from The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma
9. Supplementary Figure 1 from Lupeol Suppresses Cisplatin-Induced Nuclear Factor-κB Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model
10. Supplementary Figure 3 from Lupeol Suppresses Cisplatin-Induced Nuclear Factor-κB Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model
11. Supplementary Figure Legends 1-6 from The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma
12. Supplementary Figure 2 from Lupeol Suppresses Cisplatin-Induced Nuclear Factor-κB Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model
13. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
14. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter
15. Survival analysis of high‐intensity focused ultrasound ablation in patients with small hepatocellular carcinoma
16. Outcomes of central bisectionectomy for hepatocellular carcinoma
17. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
18. Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma
19. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma
20. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
21. Safety and Efficacy of Radiofrequency Ablation for Periductal Hepatocellular Carcinoma with Intraductal Cooling of the Central Bile Duct
22. Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma
23. Significance of CD90 + Cancer Stem Cells in Human Liver Cancer
24. Decreasing the Pancreatic Leak Rate After Pancreaticoduodenectomy
25. Portal Venous Gas and Pneumatosis Intestinalis in Necrotizing Pancreatitis
26. Current techniques of liver transection
27. A Phase I/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting Bead
28. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma
29. Clinical significance of serum angiocidin levels in hepatocellular carcinoma
30. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma
31. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
32. Molecular pathways in hepatocellular carcinoma
33. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma
34. Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin
35. Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challenge
36. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma
37. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1
38. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma#
39. Comparison of Early Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Management of Acute Biliary Pancreatitis: A Prospective Randomized Study
40. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
41. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials
42. Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients
43. Radiofrequency Ablation for Hepatocellular Carcinoma and Metastatic Liver Tumors: A Comparative Study
44. Angiogenesis in Cancer
45. Emergency surgery for obstructing colorectal cancers: a comparison between right-sided and left-sided lesions
46. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis
47. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management
48. A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
49. Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma
50. Corrigendum to “Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma” [J Hepatol 2015;62:607–616]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.